By computing the intersection of these machine-learning-predicted core target genes, five of them (TUBB3, JUN, EPHA2, FOS, and CDKN1C) were identified as the target hub genes of CRC treatment with LWMX pills (Figure 4g). The gene discussed is TUBB3; the disease is colorectal carcinoma.